China Jo-Jo Drugstores (CJJD) Reports Q2 EPS of $0.04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall St gains on bright earnings, megacaps' support
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil falls back after robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Apple, PepsiCo, JetBlue fall premarket; Amazon, GM and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
China Jo-Jo Drugstores Reports Fiscal 2017 Second Quarter Results
November 14, 2016 9:15 AM ESTHANGZHOU, China, Nov. 14, 2016 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) today announced the financial results for its second fiscal quarter and six months ended September 30, 2016.
Second Quarter Highlights:
Revenue was $20.2 million compared to $22.6 million a year ago; Gross profit increased 9.5% year-over-year to $4.4 million; Gross margin increased 4% year-over-year to 21.6%, retail pharmacy gross margin increased 7.1% to 29.4% from a year ago; GAAP net income was $97,870 or $0.01 per diluted share compared to net income of $151,175 or $0.01 per diluted share a year ago; Adjusted net... More
